Targos Development

Biomarker R&D

 

Conducting outstanding research and delivering world-class customer service is in our “DNA”. We believe that external academic sources of knowledge, partnered with professional development expertise, can drive innovation. 

Based on this collaborative culture and thinking, we started Targos Development. Co-development projects for selected companion diagnostics and proprietary development projects find their home in this division.​

In collaboration with our large network of academic institutions such as Universities of Cologne, Frankfurt, Göttingen and Essen or the UPenn Medical School or Queesn University in Belfast, we explore biomarker application, which may find future application in clinical devlopment

Currently, the main areas of interests are:

  • Development of robust Multiplex IHC / IF protocols
  • Development of AI algorithms for therapy prediction